Oxford Genome Sciences this week said Christopher Hibberd has joined its board. Hibberd is currently CEO of Astute Medical. Prior to that, he was senior vice president of corporate development at Biosite where he was responsible for identifying and pursuing strategic business opportunities.
George Adam, Christopher Hibberd
Applera, the parent company of Applied Biosystems and Celera, last week named George Adam to its board, expanding it to 11 members. The move anticipates the retirement of some current board members during the next several years and a need for additional directors if Applied Biosystems and Celera are split into independent companies, each with its own board, Applera said in a statement.
In early August, Applera said that it had retained Morgan Stanley to explore alternatives to its current corporate tracking stock structure, including possibly spinning out the two companies [See PM 08/09/07].